Cointime

Encellin

company

About

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics.

  • San Francisco,California,United States
  • 1 - 10

Highlights

Total Funding Amount
$5.90M
Funding Rounds
3
Investors
6
Employee Profiles
14

Details

Last Funding Type
Seed
Last Funding Money Raised
$5.90M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical Device
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes.

It was founded in 2016 and is headquartered in San Francisco, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$5.90M
Encellin has raised a total of $5.90M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2021 Seed $5.90M 4 Khosla Ventures
SV Latam Capital 		— Detail
Aug 22, 2019 Seed — 4 — — Detail
May 1, 2017 Grant — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
2
6
Encellin is funded by 6 investors. Khosla Ventures and SV Latam Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Khosla Ventures Yes Seed
SV Latam Capital Yes Seed
Sand Hill Angels — Seed
Y Combinator — Seed
Formic Ventures — Seed
MedTech Innovator — Grant

Employee Profiles

Number of Employee Profiles
14
Encellin has 14 current employee profiles, including Employee Ronald Martell
Ronald Martell
Employee
Aaron Tward
Advisor
Grace Wei
Executive
Vern Norviel
Employee
Crystal Nyitray
Executive
Show More
Cointime
İçerikler
Şirket.